DABUR:NSEDabur India Limited Analysis
Data as of 2026-06-06 - not real-time
₹424.15
Latest Price
4/10Risk
Risk Level: Medium
Executive Summary
Dabur India is trading at INR 424.15, below its 20‑day SMA of 447.30 and 50‑day SMA of 442.91, but still well above the 200‑day SMA of 491.49, indicating a short‑term pull‑back within a longer‑term downtrend. The RSI of 35.9 suggests the stock is approaching oversold territory, while the MACD line remains bearish with a widening histogram, pointing to lingering downside momentum. Support sits near INR 414.6 and resistance at INR 485, framing the current price action in a tight range. Recent Q4 FY26 results showed a 15% jump in net profit and a 7.3% revenue rise YoY, reinforcing the company's steady growth narrative, and a dividend of 8.25 ₹ per share (≈1.95% yield) was declared, supporting income‑focused investors. However, the DCF‑derived fair value of INR 191.36 versus the market price implies a substantial valuation gap, reflected in a high trailing PE of 39.8×. With a low beta of 0.38, increasing volume, and a “Extreme Greed” sentiment index, the stock presents a nuanced risk‑reward profile.
Given the overvaluation, modest upside of ~24% from analyst targets, strong cash balance, low debt‑to‑equity, and a sustainable dividend payout, Dabur remains attractive for long‑term holders seeking brand stability, but short‑term traders should respect the bearish technical cues and the proximity to key support levels.
Given the overvaluation, modest upside of ~24% from analyst targets, strong cash balance, low debt‑to‑equity, and a sustainable dividend payout, Dabur remains attractive for long‑term holders seeking brand stability, but short‑term traders should respect the bearish technical cues and the proximity to key support levels.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price near immediate support at INR 414.6
- Bearish MACD momentum despite oversold RSI
- Increasing volume indicating potential accumulation
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Consistent revenue and profit growth in FY26
- Strong cash position and manageable debt
- Attractive dividend yield with sustainable payout
Long Term
> 3 yearsNeutral
Model confidence: 6/10
Key Factors
- Robust brand moat in consumer defensive sector
- Significant valuation premium over DCF fair value
- Low beta and defensive positioning reduce market volatility
Key Metrics & Analysis
Financial Health
Revenue Growth7.30%
Profit Margin14.36%
P/E Ratio39.8
ROE16.24%
ROA7.35%
Debt/Equity10.91
P/B Ratio6.6
Op. Cash Flow₹25.8B
Free Cash Flow₹16.7B
Technical Analysis
TrendNeutral
RSI35.9
Support₹414.60
Resistance₹485.00
MA 20₹447.30
MA 50₹442.91
MA 200₹491.49
MACDBearish
VolumeIncreasing
Fear & Greed Index83.02
Valuation
Fair Value₹191.36
Target Price₹527.11
Upside/Downside24.27%
GradeOvervalued
TypeGrowth
Dividend Yield1.95%
Risk Assessment
Beta0.38
Volatility27.50%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.